Authors: Abraham, EH Sterling, KM Kim, RJ Salikhova, AY Huffman, HB Crockett, MA Johnston, N Parker, HW Boyle, WE Hartov, A Demidenko, E Efird, J Kahn, J Grubman, SA Jefferson, DM Robson, SC Thakar, JH Lorico, A Rappa, G Sartorelli, AC Okunieff, P

Citation: Eh. Abraham et al., Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR aswell as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis, BL CELL M D, 27(1), 2001, pp. 165-180

Authors: Rappa, G Lorico, A Hildinger, M Fodstad, O Baum, C

Citation: G. Rappa et al., Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents, HUM GENE TH, 12(14), 2001, pp. 1785-1796

Authors: Murren, JR DiStasio, SA Lorico, A McKeon, A Zuhowski, EG Egorin, MJ Sartorelli, AC Rappa, G

Citation: Jr. Murren et al., Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies, CANCER J, 6(4), 2000, pp. 256-265

Authors: Rappa, G Shyam, K Lorico, A Fodstad, O Sartorelli, AC

Citation: G. Rappa et al., Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16), ONCOL RES, 12(3), 2000, pp. 113-119

Authors: Rappa, G Murren, JR Johnson, LM Lorico, A Sartorelli, AC

Citation: G. Rappa et al., Novobiocin-induced VP-16 accumulation and MRP expression in human leukemiaand ovarian carcinoma cells, ANTI-CAN DR, 15(2), 2000, pp. 127-134

Authors: Rappa, G Finch, RA Sartorelli, AC Lorico, A

Citation: G. Rappa et al., New insights into the biology and pharmacology of the multidrug resistanceprotein (MRP) from gene knockout models, BIOCH PHARM, 58(4), 1999, pp. 557-562